Author:
Frommeyer Gerrit,Brücher Benedict,von der Ahe Henning,Kaese Sven,Dechering Dirk G.,Kochhäuser Simon,Bogossian Harilaos,Milberg Peter,Eckardt Lars
Funder
German Cardiac Society (G.F.)
Dr. Peter Osypka Foundation
Reference30 articles.
1. Administration., 2011. U.F.a.D., FDA Drug Safety Communication: Abnormal Heart Rhythms associated with High Doses of Celexa (Citalopram hydrobromide). August 24.
2. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes;Antzelevitch;Heart Rhythm,2005
3. Prolonged QTc interval and torsades de pointes induced by citalopram;Deshmukh;Tex. Heart Inst. J.,2012
4. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia: effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia;Dhein;Naunyn-Schmiedeberg’s Arch. Pharmacol.,2008
5. Experimental models of torsade de pointes;Eckardt;Cardiovasc. Res.,1998
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献